www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

CHINA> News
Race against time to produce flu vaccine
By Ding Qingfen (China Daily)
Updated: 2009-09-10 08:38

Race against time to produce flu vaccine
A technician works on a production line of the Inactivated H1N1 Influenza Vaccine in Sinovac Biotech Ltd, a Chinese vaccine making company, in Beijing. Chinese vaccine maker Sinovac has received approval from Chinese health authorities to mass produce a vaccine for the H1N1 strain of flu. [Agencies]

The 10 Chinese vaccine producers appointed by the government to develop the H1N1 Influenza vaccines are racing against time to finish clinical trials and start mass-producing the drug before the start of the flu season in October.

Beijing Sinovac Biotech, China's leading vaccine manufacturer and one of the 10 producers, received a license for producing vaccines from the State Food and Drug Administration (SFDA) on Sept 3 after the vaccine it developed was approved by a panel of experts.

The vaccine, called Panflu 1, is the first to receive official approval for production worldwide. It means China is likely to be the first nation that could mass-produce a vaccine against the flu.

On July 28, Sinovac Biotech, a joint venture between SinoBioway Group and Sinovac Biotech Ltd, a listed company on the New York Stock Exchange, announced the preliminary clinical trial showed the vaccine was "safe and effective". It was the first in the world to complete preliminary clinical trials.

The preliminary result came from injecting 1,614 volunteers in China.

Currently, there are six Chinese vaccine producers among the 10 that have finished clinical trials and applied for production certificates from the Chinese government. Henan-based Hualan Biological Engineering is expected to be the second company to receive production approval.

Race against time to produce flu vaccine

Industrial sources said most of the 10 vaccine producers would finish clinical trials around October.

Panflu 1 can safely be given to people aged from three to 60 years old in a single 15 microgram dose, according to the evaluation report.

Sinovac Biotech has the capacity to produce 5 million doses of vaccine before Oct 1, and 20 million to 30 million doses per year, said its president, Yin Weidong.

By the end of this year, China will produce H1N1 vaccines for 65 million people, covering 5 percent of the national population.

Suggested groups for vaccination are healthcare workers, who are more likely to be exposed to the virus, pregnant women, people aged above six months with chronic medical conditions such as respiratory and cardiovascular diseases, healthy adults aged 15-49 and children.

Given the population size, Chinese vaccine manufacturers will face a huge challenge meeting the potential needs with limited production capacity, said Keiji Fukuda, assistant director-general of the World Health Organization.

Xinhua reported that the Mexican government would buy 10 million doses of H1N1 flu vaccine from China, bringing its stockpile to 30 million doses, nearly 30 percent of its population.

An online survey by the news portal Sohu.com found that 68.4 percent of the 2,269 respondents said they wanted to be vaccinated.

 

 

主站蜘蛛池模板: 欧美18在线| 久久福利青草精品资源 | 一级毛片不收费 | 久久精品一区二区三区中文字幕 | 最新久久免费视频 | 手机看片自拍日韩日韩高清 | 一级做a毛片在线看 | 成年美女黄网站色视频大全免费 | 色偷偷成人网免费视频男人的天堂 | 欧美成年黄网站色视频 | 国内美女福利视频在线观看网站 | 久久国产一级毛片一区二区 | 日本高清乱偷www | 米奇精品一区二区三区 | 国产一区视频在线 | 国产三级日本三级在线播放 | 国产精品日本欧美一区二区 | 中文字幕欧美日韩一 | 一级特黄性色生活片一区二区 | 一级做a爱片久久蜜桃 | 爽爽在线 | 久久久久免费视频 | 国产日韩亚洲不卡高清在线观看 | 亚洲伦乱 | 国产亚洲一欧美一区二区三区 | 国产免费亚洲 | 日本特黄乱人伦片 | 国产精品国产三级国产an不卡 | 最新亚洲情黄在线网站无广告 | 午夜精品成人毛片 | 日韩欧美印度一级毛片 | 亚洲天堂国产精品 | 久久福利青草免费精品 | 18成人网| 日韩精品欧美国产精品亚 | 国产成人精品系列在线观看 | 欧美亚洲在线视频 | 久草资源在线 | 国产精品久久久久一区二区三区 | 亚洲www色| 国产欧美久久久精品 |